IgA Nephropathy Clinical Trials in Paris
5 recruitingParis, France
Showing 1–5 of 5 trials
Recruiting
Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
IgA NephropathyDiabetic NephropathiesANCA-associated Vasculitis+4 more
Assistance Publique - Hôpitaux de Paris146 enrolled1 locationNCT07010250
Recruiting
RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)
IgA Nephropathy (IgAN)
Assistance Publique - Hôpitaux de Paris800 enrolled1 locationNCT06926244
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
Primary IgA Nephropathy
Hoffmann-La Roche428 enrolled204 locationsNCT05797610
Recruiting
Phase 2
Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study
IgA Nephropathy
Centre Hospitalier Universitaire de Saint Etienne334 enrolled7 locationsNCT06350630
Recruiting
Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Primary IgA Nephropathy
Novartis Pharmaceuticals540 enrolled161 locationsNCT04557462